Project Grant HT94252410697
Award Date 8/1/24
Completion Date 7/31/27
Dollars Obligated $825K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Similar Awards
- The U.S. Defense Health Agency awarded a $825,000 Project Grant to Delix Therapeutics, Inc. in Palo Alto, CA under the Military Medical Research and Development program (CFDA 12.420). The funding will support the "DEVELOPMENT OF SMALL-MOLECULE TREATMENT FOR HEARING LOSS" over a 3-year period from June 1, 2024 to May 31, 2027. The Military Medical Research and Development program provides grants to academic institutions, research centers, and medical universities to conduct biomedical...
- The U.S. Defense Health Agency awarded Sunnybrook Research Institute, a Canadian non-profit research organization, a $302,500 Project Grant (CFDA 12.420 - Military Medical Research and Development) to conduct research focused on "Dissecting Biological Mechanisms Underlying Behavioral Heterogeneity in Autism." The 3-year project, running from Apr 1, 2024 to Mar 31, 2027, aims to investigate the biological underpinnings of the varied behaviors observed in individuals with autism spectrum...
- The U.S. Defense Health Agency awarded a $1,170,000.00 Project Grant to the Regents of the University of Michigan for the "Systemically Administered Bispecific Antibodies that Activate Neurotrophin Receptors for Treating Noise-Induced Inner Ear Damage" research project. This grant, under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at developing innovative medical solutions to address critical health challenges...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $358,245 Project Grant to the Massachusetts Eye And Ear Infirmary on May 15, 2024 for the project "IN SILICO SCREEN AND IN VIVO EVALUATION OF FDA-APPROVED DRUGS TO TREAT NOISE-INDUCED HEARING LOSS". The grant supports a two-year effort to screen FDA-approved drugs and evaluate the most promising compounds for their ability to protect against noise-induced hearing loss in cell...
- The Defense Health Agency has awarded a $1,370,529 Cooperative Agreement under the Military Medical Research and Development program (CFDA 12.420) to the Massachusetts Eye and Ear Infirmary. The funding supports a 3-year project to investigate the regeneration of synapses to treat synaptopathy (damage to synaptic connections) following noise exposure, with the goal of transforming healthcare for Service Members and the American public. As a sub-award under this grant, The Geneva Foundation...
- The University of Miami received a $1,534,759 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "RESTORATION OF INNER EAR CELLS IN THE HEARING LOSS-ASSOCIATED HUMAN INNER EAR SYSTEM". This 3-year award, with a period of performance from September 30, 2023 to September 29, 2026, will support the university's biomedical research efforts focused on developing new treatments and...
- This $1.42M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Miami to prevent hidden hearing loss and synaptopathy following noise overexposure through targeted temperature management. The 3-year grant, awarded on July 15, 2023, will fund this study focused on improving medical solutions for the battlefield and transforming health care for Service Members and the public through...
- The Department of the Army Medical Command awarded Case Western Reserve University a $402,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support the repurposing of a therapeutic candidate to mitigate synaptopathy and associated hearing loss. The two-year award, beginning September 1, 2021, will fund research activities at Case Western Reserve University and its affiliated University Hospitals of Cleveland location in Cleveland, Ohio to...
- The University of Pittsburgh was awarded a $1,148,334 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop viral delivery strategies for targeted hair cell regeneration. The project, with a performance period from May 15, 2025 to May 14, 2028, aims to transform healthcare for military service members and the broader public through innovative biomedical research. The university's robust research infrastructure and...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this...